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Abstract
Composite fibrous electrospun membranes based on poly(DL-lactide) (PLA) and poly(ε-
caprolactone) (PCL) were engineered to include borate bioactive glass (BBG) for the potential 
purposes of guided bone regeneration (GBR). The fibers were characterized using scanning and 
transmission electron microscopies, which respectively confirmed the submicron fibrous 
arrangement of the membranes and the successful incorporation of BBG particles. Selected 
mechanical properties of the membranes were evaluated using the suture pullout test. The addition 
of BBG at 10 wt.% led to similar stiffness, but more importantly, it led to a significantly stronger 
(2.37±0.51 N*mm) membrane when compared to the commercially available Epiguide® 
(1.06±0.24 N*mm) under hydrated conditions. Stability (shrinkage) was determined after 
incubation in a phosphate buffer solution from 24 h up to 9 days. The dimensional stability of the 
PLA:PCL-based membranes with or without BBG incorporation (10.07-16.08%) was similar to 
that of Epiguide® (14.28%). Cell proliferation assays demonstrated a higher rate of pre-osteoblasts 
proliferation on BBG-containing membranes (6.4-fold) over BBG-free membranes (4-5.8-fold) 
and EpiGuide® (4.5-fold), following 7 days of in vitro culture. Collectively, our results 
demonstrated the ability to synthesize, via electrospinning, stable, polymer-based submicron 
fibrous BBG-containing membranes capable of sustaining osteoblastic attachment and 
proliferation—a promising attribute in guided bone regeneration.
Introduction
Periodontitis, a chronic inflammatory disease affecting the gingiva, periodontal ligament, 
cementum, and underlying alveolar bone, is the leading cause of tooth loss in adults. Indeed, 
according to the literature, the prevalence of varying degrees of periodontitis in the United 
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States has been estimated to affect 47.2 percent of the adult population, or 64.7 million 
American adults.1
Current treatment strategies for patients suffering from moderate-to-severe periodontal 
destruction often result in some form of periodontal repair; however, the goal should be the 
de novo regeneration of lost periodontal tissues, including the formation of gingiva, alveolar 
bone, a functionally-oriented periodontal ligament (PDL), and cementum.1-2 Regeneration 
of periodontal defects has been achieved following the principle of tissue exclusion, termed 
guided tissue regeneration (GTR), when planned around root surfaces, or guided bone 
regeneration (GBR), when discussing bone defects at potential implant sites. Regenerative 
procedures typically involve utilization of a barrier membrane to prevent more rapidly 
growing epithelial tissue from migrating into the defect, allowing adequate time for the 
formation of PDL, cementum, and bone.1-6
Existing GTR/GBR membranes are often composed of synthetic polymers, which may be 
non-resorbable (i.e., polytetrafluoroethylene, PTFE) or resorbable (e.g., poly(lactide), PLA, 
and poly(ε-caprolactone), PCL). Additionally, membranes may be composed of natural 
polymers (e.g., collagen) combined or not combined with synthetic ones.7-14 Even though 
several studies have shown that non-resorbable membranes are capable of demonstrating 
structural stability while providing an adequate environment for periodontal regeneration,15 
the need for a secondary surgery for membrane removal still represents a significant 
drawback. On the other hand, intrinsic problems with the available resorbable polymer-
based synthetic membranes include poor membrane stability and bone regenerative capacity. 
These problems may be due to the relatively rapid degradation, shrinkage, and collapse of 
the membrane, which, in turn, might limit new bone formation.14
Electrospinning is a process by which micro/nanofibers can be formed from a viscous 
polymer solution exposed to an electric field.14,16 Although widely used in tissue 
engineering applications,14 biocompatible PLA electrospun meshes have displayed a high 
degree of shrinkage.17-18 Importantly, Xu et al. demonstrated that combining PLA and PCL 
at certain ratios may control overall shrinkage,19 which might enable its application as a 
GTR/GBR membrane.
In recent years, the incorporation of a wide variety of bioceramics into polymer-based 
scaffolds has demonstrated great potential toward the development of bioactive membranes 
for periodontal regeneration. Co-electrospinning hydroxyapatite with collagen and/or 
synthetic polymers led to improved bioactivity, greater cell adhesion, and proliferation.20-22 
Another promising material that has been used in conjunction with polymer scaffolds is 
bioactive glass, which has the potential to induce bone formation, osteogenic proliferation, 
and activation of gene expression.23-26 Regrettably, one of the shortcomings of bioactive 
glass is its slow degradation. Interestingly, the partial or full replacement of silica with 
borate allows for greater control over the degradation rate, which is essential for bone 
regeneration.27
In the present work, borate bioactive glass (BBG) containing PLA:PCL polymer membranes 
was prepared via electrospinning. Morphological, chemical, and mechanical properties of 
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the membranes were studied in detail. In addition, membrane stability (i.e., shrinkage) over 
time was evaluated as a function of PCL incorporation. Lastly, preosteoblasts were cultured 
on the membranes to assess whether the addition of BBG could increase in vitro cell 
proliferation potentially for purposes of guided bone regeneration.
Materials and Methods
Materials
Poly(DL-lactide) (PLA, inherent viscosity 0.55–0.75 dL/g in CHCl3) and poly(ε-
caprolactone) (PCL, inherent viscosity 1.29 dL/g in CHCl3) were purchased from Lactel 
Absorbable Polymers (Durect Corporation, Birmingham, AL, USA). BBG micron-sized 
particles with an average diameter of 1.2 μm were donated from the Mo-Sci Corporation 
(Cat.#1550P, Batch #101, Rolla, MO, USA). 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) was 
used as the solvent (Sigma-Aldrich, St. Louis, MO, USA). EpiGuide®, a commercially 
available PLA-based resorbable periodontal membrane, was purchased from RIEMSER 
Pharma GmbH (Research Triangle Park, NC, USA) and used for comparative purposes.
Preparation of electrospun membranes
PLA and PCL were individually dissolved under stirring conditions in HFP to obtain 200 
mg/mL and 100 mg/mL solutions, respectively. A 50:50 (v/v) polymer blend was obtained 
by mixing equal amounts of pure PLA and PCL solution into a fresh vial via pipetting. BBG 
was added to the PLA:PCL blend at two distinct concentrations (i.e., 5 and 10 wt.%, relative 
to the total polymer mass). A two-step method was used to obtain the BBG-containing 
PLA:PCL membranes. In brief, after the PLA:PCL blend preparation, BBG particles were 
added and sonicated (90 min) to ensure good particle dispersion.28 Table I provides the 
optimized electrospinning parameters for the distinct membranes processed. The membranes 
were electrospun using a system consisting of a high-voltage source (ES50P-10W/DAM, 
Gamma High-Voltage Research Inc., Ormond Beach, FL, USA), a syringe pump (Legato 
200, KD Scientific Apparatus, Holliston, MA, USA), and a grounded stainless steel 
collecting drum (ϕ = 4 cm) connected to a high-speed mechanical stirrer (BDC6015, 
Caframo, Georgian Bluffs, ON, Canada).28 The distinct solutions were individually loaded 
into a plastic syringe fitted with a 27-gauge stainless steel needle and electrospun directly 
onto an aluminum foil-covered rotating mandrel. The fibers were collected at room 
temperature (RT). Samples were kept at RT for 2 days in a vacuum desiccator to remove any 
residual solvent.28
Membrane morphological and chemical characterizations
The fiber morphology and diameter of the resultant electrospun membranes was examined 
via scanning electron microscopy (SEM, JSM-5310LV, JEOL, Tokyo, Japan). Fiber 
morphology was imaged at 5 keV after mounting and sputter coating with Au. The mean 
fiber diameter (n=90) from three different images at the same magnification was calculated 
using ImageJ 1.40G software (National Institutes of Health, Bethesda, MD, USA).28 
Transmission electron microscopy (TEM, FEI Tecnai G20, FEI Co., Hillsboro, OR, USA) 
was also used to investigate the incorporation and distribution of BBG on electrospun 
PLA:PCL fibers. In brief, fibers composed of distinct electrospun fibrous membranes were 
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individually collected directly onto carbon-coated TEM grids during electrospinning. 
Additionally, energy-dispersive X-ray spectroscopy (EDS, EDAX/Ametek, Berwyn, PA, 
USA) was performed to assess the elemental composition of each electrospun membrane 
and the BBG used.
Mechanical suture pullout strength
Membrane tear resistance (n=4-6/group) was assessed using a suture pullout test under dry 
and wet conditions (i.e., PBS incubation for 24h at 37°C), since the mechanical behavior 
after hydration is of significant importance in predicting the in vivo clinical performance of 
the membrane.14,28 The samples were cut (40 mm × 10 mm) and the thickness was 
measured (Mitutoyo Digimatic Caliper; Mitutoyo Corporation, Tokyo, Japan) at three 
distinct positions. The samples' measurements were averaged and entered into the testing 
machine (Expert 5601®, ADMET, Norwood, MA, USA) software (Quattro®).29 The 
electrospun membranes were compared to EpiGuide®. A monofilament 2-0 suture (PDS II, 
Ethicon Z-317H) was placed 5 mm from the top edge and 5 mm from each side. The suture 
was affixed to the testing machine clamp but left unknotted. Testing was carried out at a 
crosshead speed of 1 mm/min.30 Three distinct mechanical properties (i.e., peak load, 
stiffness, and energy to break) were recorded or determined from the load-position curves.
In vitro dimensional stability
The electrospun membranes (n=3), as well as EpiGuide®, were cut into squares (10 × 10 
mm2) and incubated at 37°C in PBS (2 mL) for up to 9 days. The samples were washed with 
distilled water and dried at RT for 24 h prior to surface area measurement. Dimensional 
stability (i.e., shrinkage) ratios of the electrospun membranes before and after incubation 
were used to obtain shrinkage rates of the samples.
In vitro osteoblast culture and cell proliferation assay
Five groups of electrospun membranes (i.e., pure PLA, pure PCL, PLA:PCL with no BBG, 
PLA:PCL+5 wt.%BBG, PLA:PCL+10 wt.%BBG), and EpiGuide® were studied. The fibers 
were electrospun onto glass cover slips (ϕ=12 mm) using modification of the 
aforementioned procedure. Samples (n=4) were exposed to UV light for 15 min and placed 
into wells of 24-well plates. Glass cover slips were stabilized with plastic cell crowns 
(CellCrown™, Scaffdex, Tampere, Finland) to prevent them from floating in culture wells. 
Additionally, samples were disinfected by adding 2 mL of 70% ethanol for 30 min, rinsed 
once with 2 mL of sterile 0.9% PBS, and soaked with 0.5 mL of minimum essential medium 
(MEM) supplemented with 10% fetal bovine serum, 1% L-glutamine, and a 1% antibiotic 
and formulation (penicillin G sodium, streptomycin sulfate) medium for 30 min.
Mouse-calvaria-derived pre-osteoblasts (ATCC, CRL-2593, American Type Culture 
Collection, Rockville, MD, USA) previously cultured in MEM were harvested and seeded at 
passage 15 on each of the experimental membranes at a density of 10,000 cells per well in a 
total volume of 300 μL of complete media. The cultures were kept at a constant temperature 
of 37°C, 5% CO2 in a humidified atmosphere.31 Replacement of the culture medium was 
performed every other day. Cell proliferation was assessed using the PMS-MTS one solution 
viability kit (Promega Corporation, Madison, WI, USA) after 3, 5, and 7 days. The assay's 
Rowe et al. Page 4
J Biomed Mater Res B Appl Biomater. Author manuscript; available in PMC 2017 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
functionality is mostly due to the measurement of NADH+H+ production, causing reductive 
cleavage of tetrazolium salt to the soluble formazan.31 A total 60 μL of the assay reagent 
was added to each sample containing 300 μL of MEM. Following 2 h of incubation at 37oC 
and 5% CO2 in a humidified atmosphere, 100 μL from each 24-wells plate was transferred 
into wells of a 96-wells plate in triplicate and absorbance was determined at 490 nm. The 
MC3T3-E1 cells, seeded directly onto 24-wells plates, served as a high control. As a 
background, optical density measured at 650 nm was used for samples, per the 
manufacturer's recommendations. Four samples per time point were used to determine the 
number of cells attached to the electrospun fibers, as well as to EpiGuide®. Two additional 
samples per group and per time point were included in the cell experiment to qualitatively 
observe the morphology of the cells via SEM. The cells cultured on glass substrates were 
used as a positive control.31 Briefly, following removal of the samples from the culture 
medium, the samples were fixed in buffered 4% formaldehyde (Sigma) and washed with 
PBS to remove unbound cells. Next, the samples were dehydrated using ascending ethanol 
gradients (30, 50, 70, 90, and 100%) and soaked in ethanol/hexamethyldisilazane (HMDS) 
gradients (Sigma). Then, the membranes were incubated in 100% HMDS and allowed to 
airdry. Finally, the samples were mounted on aluminum stubs, sputter-coated with Au, and 
imaged using SEM.29
Statistical analyses
Kruskal-Wallis and Student-Newman-Keuls statistical analyses were performed for fiber 
diameter. Two-way ANOVA was used to test the effects of the group (i.e., Epiguide®, PLA, 
PCL, PLA:PCL, PLA:PCL+5wt.%BBG, and PLA:PCL+10wt.%BBG) and hydration status 
(i.e., dry vs. wet), and their interaction on the distinct mechanical properties were evaluated. 
A natural log transformation of the outcomes was used for analysis. Two-way ANOVA 
analyses were used for dimensional stability assessment and cell proliferation. Statistical 
significance was set at p<.05.
Results
Membrane morphological (SEM/TEM) and chemical characterizations
The mean fiber diameter of the synthesized electrospun membranes ranged from 0.09 to 
1.95 μm as follows: PLA (1.25±0.12μm), PCL (0.49±0.31μm), PLA:PCL (0.92±0.13μm), 
PLA:PCL+5wt.%BBG (0.61±0.11μm), and PLA:PCL+10wt.%BBG (0.52±0.12μm) 
(Figures 1 and 2). The PLA fibers (Figure 1A) were thicker when compared to the PCL 
fibers (Figure 1B). The mean diameter of the PLA:PCL fibers was between that of pure PLA 
and pure PCL fibers (Figure 1C). The commercially available PLA membrane (i.e., 
EpiGuide®) demonstrated varying fiber diameters and pore sizes that were generally larger 
than those found in the electrospun membranes (Figure 1D). There was no significant 
difference in the mean diameter of 5wt.%- and 10wt.%0-BBG-incorporated PLA:PCL fibers 
(Figures 2C-2F). Incorporation of BBG decreased the mean fiber diameter when compared 
to pure PLA, PCL, and PLA:PCL fibers (p<0.05). BBG particles could be visualized as 
swollen areas, as well as crystal structures on the otherwise smooth PLA:PCL fibers 
(Figures 2C-2F). It is worth mentioning that a greater amount of BBG particles was 
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observed on the surface of the PLA:PCL+10 wt.%BBG (Figure 2E) than PLA:PCL+5 wt.
%BBG fibers (Figure 2C).
Energy-dispersive X-ray spectroscopy (EDS) was used to assess the elemental composition 
of the electrospun membranes and the BBG micron-sized particles (Figure 3). PLA, PCL, 
and PLA:PCL demonstrated similar spectra-containing traces of carbon, oxygen, and 
fluorine. BBG particles displayed oxygen, sodium, magnesium, phosphorus, potassium, and 
calcium peaks. PLA:PCL+5wt.%BBG and PLA:PCL+10wt.%BBG samples both showed 
the characteristic polymer-related peaks in addition to those present in the BBG particles. 
TEM was done to further confirm the successful incorporation of BBG on PLA:PCL 
blended fibers. The PLA (Figure 4A), PCL (Figure 4B), and PLA:PCL (Figure 4C) fibers 
were smooth. On the other hand, the incorporation of BBG made the fibers apparently 
rougher and uneven. Similar to the SEM images, BBG particles were more on the surface of 
the PLA:PCL+10 wt.%BBG fibers (Figure 4E) as compared to that of the PLA:PCL+5 wt.
%BBG fibers (Figure 4D).
Mechanical suture pullout strength
Under dry conditions, electrospun PLA had significantly (p<0.05) higher pullout strength 
(i.e., peak load, Table II and Figure 5A) than all the other electrospun membranes and 
EpiGuide®. Meanwhile, the dry pullout strength of PCL, PLA:PCL, and PLA:PCL, with 
distinct amounts of incorporated BBG particles, were statistically similar (p>0.05). Notably, 
the PLA:PCL+10wt.%BBG membranes were significantly stronger than EpiGuide® 
(p<0.05) (Table II and Figure 5A). However, under wet conditions, the BBG-incorporated 
membranes presented similar strength when compared to the clinical reference (i.e., 
EpiGuide®). PLA:PCL electrospun membranes performed better than EpiGuide® under both 
dry and wet conditions. Overall, the addition of BBG particles did not improve membrane 
strength when compared to Epiguide®, except when BBG particles were added at 10 wt.% 
and tested under dry conditions.
Membranes based on the PLA:PCL blend demonstrated significantly lower stiffness values 
when compared to the PLA (Table II). The addition of BBG did not compromise this 
property, and more importantly, the obtained values were statistically similar to Epiguide®. 
As far as the influence of hydration is concerned, PLA:PCL+10wt.%BBG and Epiguide® 
revealed statistically similar stiffness values after 24 h of immersion in PBS (Table II). 
Lastly, concerning the energy to break, under dry conditions, the pure PLA and PLA:PCL
+10wt.%BBG displayed the highest values (not statistically significant), followed by 
PLA:PCL, pure PCL, Epiguide®, and PLA:PCL+5wt.%BBG. After hydration, a significant 
decrease in the energy to break was seen for PLA:PCL+10wt.%BBG when compared to the 
PLA membranes but it remained significantly higher than Epiguide® (Table II and Figure 
5B).
In vitro dimensional stability
Two-way ANOVA was used to test the effects of the dimensional stability (shrinkage, %) in 
each group, time, and their interaction (Table III). Overall, PLA demonstrated the highest 
dimensional variation among groups and time. PLA:PCL demonstrated the least dimensional 
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variation during the 24 h to 4-day period compared to those following 9 days of incubation. 
The addition of BBG particles led to a decrease in dimensional stability. PLA:PCL 
membranes behaved similarly to EpiGuide®; that is, they demonstrated an increasing 
shrinkage from day 1 to day 9.
Cell proliferation
Cell proliferation on PLA:PCL+10 wt.%BBG samples was significantly higher when 
compared to PLA, PCL, and PLA:PCL at day 5 (Table IV). No significant differences in 
proliferation were noted between the 5 and 10 wt.%-BBG-containing membranes at all time 
points. Only at day 7 did the addition of BBG particles reveal an increase in cell 
proliferation over that seen on EpiGuide®. Generally, cell proliferation among groups was 
greatest at day 7, with diminished proliferation compared to days 5 and 3, respectively. 
Although the addition of BBG particles did not demonstrate a significant improvement in 
cell proliferation at days 3 and 5, it did show a slight enhancement over EpiGuide® by day 
7. SEM images (Figure 6A-D) demonstrated a fairly well spread-out positioning of the 
MC3T3-E1 preosteoblasts over the surface of the electrospun membranes with extensions of 
pseudopodia surrounding the center of the cells.
Discussion
The electrospinning technique has been employed in tissue engineering and is useful for 
synthesizing novel biomaterials, with favorable mechanical and biological properties that 
provide adequate surface architecture to promote cell attachment and proliferation.30-36 The 
electrospun collagen fiber diameter has been shown to range from 100 to 500 nm.21 In our 
study, the incorporation of BBG particles at a concentration of 5 and 10 wt.% to the 
PLA:PCL blend led to a considerable reduction in mean fiber diameter when compared to 
pure PLA:PCL (Figures 2C-2F), closely resembling the diameter of collagen fibers in bone 
tissue.22 According to Jeong et al., possible changes in solution viscosity due to the 
incorporation of inorganic particles (e.g., hydroxyapatite nanoparticles) may significantly 
contribute to the decrease in fiber diameter.35
Considering that the clinical application of periodontal membranes generally requires 
suturing or tacking for stabilization into the specific location,14,30 a suture pullout strength 
test was used to determine the membranes' resistance to tearing under tensile forces.30 
Although incorporation of a relatively high concentration of BBG (i.e., 10wt.%) led to a 
substantial improvement in the energy to break (i.e., the area under the load vs. displacement 
curve) of the PLA:PCL+10wt.%BBG electrospun membrane under dry conditions, most 
probably due to the reinforcing effects of the BBG particles, a significant decrease in this 
property was seen after immersion in PBS (37°C, 24 h). Based on the hydrophilic nature of 
the BBG particles, as well as the SEM findings that revealed a substantial amount of BBG 
particles at the membrane's surface, one can assume that the membrane experienced an 
increased PBS absorption/uptake. This can provide a localized plasticizing effect due to 
absorbed water, which is hydrogen-bonded to hydrophilic BBG surfaces at the regions of 
high BBG particles' density or BBG aggregates in the hydrophobic PLA:PCL fibers (formed 
as a result of incomplete dispersion of BBG particles), which, in turn, can affect mechanical 
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strength. In a previous study conducted by our group using nano-hydroxyapatite (nano-
HAp)-incorporated electrospun fibrous scaffolds, we have observed a more pronounced 
fiber breakage, which resulted in a decrease in mechanical strength due to the surface 
erosion of embedded particles or as the nano-HAp content in fiber increases. One or both of 
these effects could be the reasons for the reported energy to break drastic drop (Table II) in 
the case of PLA:PCL incorporated with 10wt.%BBG in wet conditions as compared to the 
other groups. Notably, for the clinical success of regenerative therapy, it is paramount that a 
balance between stiffness and elasticity be achieved in the synthesis of novel 
membranes.14,28 It is well known that membranes should be stiff enough to bear the 
compressive forces exerted by the overlying soft tissue and mastication,28 until proper 
maturation of the blood clot builds underneath the membrane. Meanwhile, a very stiff 
membrane would not allow for good clinical manageability or utilization, since, often times, 
one has to cut and shape the membrane to adapt to the morphologically distinct periodontal 
defects.14,28,37-38 Most importantly, the overall properties of the electrospun membrane 
incorporated with BBG at 10wt.% presented comparable or superior mechanical properties 
to that of a clinically available PLA-based membrane.
Considering the intended clinical application in regenerative periodontics as GTR/GBR 
membranes, we assessed in vitro their dimensional stability over time. Worth mentioning, 
based on the collected data, one could also consider the potential incorporation of BBG 
particles into the PCL membrane, as the PCL fibrous membranes showed (numerically) 
better dimensional stability by day 9, even though they were not statistically different from 
the PLA:PCL blend membrane. Taken together, the better mechanical properties displayed 
by the PLA:PCL blend membrane when compared to the pure PCL further supports 
incorporation of the BBG particles into the blend polymer system. Further studies are 
necessary to investigate the role of BBG particles when incorporated into the PCL 
membrane in terms of fiber dimension, mechanical property, dimensional stability, and cell-
membrane interaction.
In recent years, numerous research groups have focused on the development of membranes 
for GTR/GBR applications that are capable of not only hindering epithelial tissue infiltration 
into the periodontal defect, but more importantly, promoting faster bone growth through the 
wise addition of calcium phosphates and bioactive glass particles.14 One might possibly 
argue about the actual amount of BBG incorporated into the electrospun PLA:PCL fibers. It 
is worth mentioning that we employed a similar particle dispersion strategy to that 
previously reported by our group when synthesizing polymer fibers incorporated with 
hydroxyapatite (n-HAp) particles. According to our previous data, based on 
thermogravimetric (TGA) analysis, the theoretical addition of 10wt.% of HAp particles into 
the polymer solution led to the actual incorporation of 10.6± 2.6wt.%, indicating good 
dispersion of n-HAp in the fibers and overall success of the processing approach.28 Further 
research should be performed to better understand the dissolution rate and overall 
degradation of the BBG particles used herein when incorporated into electrospun polymer 
fibers after long-term storage in a clinically relevant physiological environment. 
Nonetheless, silicate and borate-based bioactive glasses are extensively investigated for 
biomedical applications to enhance bone repair/regeneration. Although both are 
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osteoconductive, borate-based bioactive glasses degrade faster and convert to calcium 
phosphate at a remarkably rapid rate that bonds with the surrounding tissue.39 Particles of 
borate bioglass, designated as 45S5B1, were almost completely converted to hydroxyapatite 
in less than 4 days when immersed in a 0.02 M K2HPO4 solution with a starting pH value of 
7.0 at 37°C.40,41
In this study, cell proliferation revealed being influenced by time and the group of 
membranes used. While the cells are fairly well-defined for the electrospun membranes, it is 
more difficult to distinguish cell borders on the EpiGuide® membranes (Figure 5E). This 
may be due to cell in-growth along the pores, and within the pores of Epiguide®, which are 
visually larger than the pores of electrospun membranes. The distribution and surface-
coverage of the pre-osteoblasts on electrospun membranes appear to be similar, regardless of 
the presence of BBG particles. Hence, there was an increased proliferation of pre-osteoblasts 
on the surface of BBG-incorporated membranes by day 7. Notably, borate glass particles 
with diameters of 212–355 μm have been shown to support the attachment, growth, and in 
vitro osteogenic differentiation of mesenchymal stem cells.42 This increased cell 
proliferation might also be due to the increased surface roughness of the BBG-incorporated 
fibers when compared to the smooth PCL, PLA, and PLA:PCL fibers. A study by Fu et al. 
demonstrated that, when osteogenic MLO-A5 cells were cultured on borate bioglass 
scaffolds, a reduced cell viability was observed due to the high concentration of boron ions 
released into the media, even though these scaffolds supported soft tissue infiltration in vivo. 
Nonetheless, we did not observe any meaningful reduction in cell attachment, which might 
be correlated to the relatively small percentage of BBG used, which was not sufficiently 
high to induce cell toxicity. One should note that the scope of the cell-related work 
presented in this study was restricted. Future studies using these novel BBG-incorporated 
membranes should investigate cell-membrane compatibility using other cell types (e.g., 
periodontal ligament fibroblasts). Furthermore, the effects of BBG incorporation should be 
studied in detailed at the molecular level to clarify their role in pre-osteoblasts' cell functions 
and differentiation before in vivo testing using GTR/GBR periodontal defect models.
Polymer-based membranes (i.e., PLA, PCL, and PLA:PCL) were fabricated via 
electrospinning. PLA:PCL membranes were also spun after the incorporation of distinct 
amounts of BBG particles into the polymer solution. The addition of PCL to PLA increased 
initial dimensional stability up to day 4 and increased overall stability over 9 days when 
compared to PLA alone. The addition of BBG did not significantly improve membrane 
strength when compared to Epiguide®, except for the addition of BBG at 10 wt.% under dry 
conditions, when testing was conducted for suture pull-out strength. The addition of PCL to 
PLA helped to control shrinkage of the electrospun membranes. Overall, the membranes 
presented a random submicron fibrous structure capable of supporting mouse-calvaria-
derived preosteoblastic cell growth and proliferation. BBG-containing membranes led to 
greater cell proliferation over BBG-free membranes and EpiGuide, following 7 days of 
culture.
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Conclusion
Clinical applications of BBG-containing electrospun membranes are vast and would include 
the fabrication of membranes containing additional biologic modifiers, such as bone 
morphogenic proteins (BMPs). Future research would need to be implemented using in vivo 
animal model, to understand the role of the proposed membranes on bone regeneration. 
Taken together, our results demonstrated the ability to fabricate, via electrospinning, stable, 
polymer-based nanofibrous BBG-membranes capable of promoting osteoblast attachment 
and proliferation, a promising attribute that supports their use in periodontal regenerative 
therapy.
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Figure 1. 
Representative SEM images of the morphological structure of (A) pure PLA, (B) pure PCL, 
(C) PLA:PCL electrospun membranes synthesized in this study and (D) commercially 
available periodontal membrane, EpiGuide®.
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Figure 2. 
(A-B) Representative TEM images of the borate-based bioglass (BBG) particles. (C-D) 
Representative SEM images of the PLA:PCL electrospun membranes modified with 5 wt.
%BBG at 5000× (C) and 10000× (D) magnifications. (E-F) Representative SEM images of 
the PLA:PCL electrospun membranes modified with 10 wt.%BBG at 5000× (E) and 10000× 
(F) magnifications. The deposition of BBG on the PLA:PCL fibers are indicated by arrows 
in the lower magnification images.
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Figure 3. 
EDS spectra of electrospun membranes and BBG particles. (A) PLA; (B) PCL; (C) 
PLA:PCL; (D) BBG particles (inset shows a representative SEM image of the BBG 
particles); (E) PLA:PCL+5 wt.%BBG; and (F) PLA:PCL+10 wt.%BBG.
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Figure 4. 
Representative TEM images showing the morphology of the electrospun fibers synthesized 
in this study. A smooth fiber morphology can be seen in (A) pure PLA, (B) pure PCL, and 
(C) PLA:PCL fibers. The incorporation of BBG, regardless of the concentration (D) 
PLA:PCL+5wt.%BBG and (E) PLA:PCL+10 wt.%BBG led to morphologically rougher 
fibers. (D-E) Note the presence of BBG particles as black agglomerates along the axis of the 
BBG-incorporated fibers.
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Figure 5. 
Representative suture pullout strength load vs. displacement curves for all the electrospun 
membranes and Epiguide® under (A) dry and (B) wet conditions.
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Figure 6. 
Representative SEM images illustrating the MC3T3-E1 cell morphology after 7 days of 
culture: (a) PLA; (b) PCL; (c) PLA:PCL; (d) PLA:PCL+10 wt.%BBG; and (e) EpiGuide®.
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TABLE II
Mechanical Properties of the Synthesized Electrospun Membranes and EpiGuide®
Group Condition Peak Load (N) Mean ± SD Stiffness (N/mm) Mean ± SD Energy to Break (N mm) Mean ± SD
PLA
Dry
1.80 ± 0.46a 5.15 ± 0.87a 7.20 ± 1.87a
PCL 0.95 ± 0.20b 2.00 ± 0.69c 3.42 ± 0.96b
PLA:PCL 0.91 ± 0.30b 2.93 ± 0.93b 3.88 ± 0.82b
PLA + PCL + 5% BBG 0.63 ± 0.15b,c 3.07 ± 0.41b,c 0.62 ± 0.16d
PLA + PCL + 10% BBG 1.23 ± 0.47b,d 2.51 ± 0.70b,c 9.06 ± 1.27a
EpiGuide® 0.55 ± 0.16c 2.40 ± 0.74b,c 1.43 ± 0.37c
PLA
Wet
1.78 ± 0.90a 7.80 ± 1.87a 8.21 ± 0.66a
PCL 0.99 ± 0.16b 1.99 ± 0.57b,c 1.96 ± 0.28c
PLA:PCL 0.78 ± 0.05b 2.64 ± 0.55c 5.05 ± 1.10b
PLA + PCL + 5% BBG 0.41 ± 0.14c 1.96 ± 0.63d,c 1.38 ± 0.39d
PLA + PCL + 10% BBG 0.43 ± 0.09c 1.40 ± 0.19b 2.37 ± 0.51c
EpiGuide® 0.44 ± 0.06c 1.68 ± 0.37b 1.06 ± 0.24d
Different lowercase letters in the same column represent statistical differences between groups.
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TABLE III
Dimensional Stability Analysis (Shrinkage, %) After 24 h, 4 and 9 Days
Group 24 h 4 days 9 days
PLA 39.12 ± 6.29aB 38.84 ± 4.03aB 48.51 ± 4.83aA
PCL 5.44 ± 4.0bA 7.95 ± 4.51bA 7.48 ± 1.66bA
PLA:PCL 1.31 ± 2.37bA 1.96 ± 6.40bA 10.07 ± 11.39bA
PLA:PCL + 5 wt % BBG 5.78 ± 2.44bA 7.73 ± 5.20bA 10.77 ± 5.56bA
PLA:PCL+10 wt % BBG 6.23 ± 1.69bB 0.81 ± 8.0bB 16.08 ± 9.33bA
EpiGuide® 2.35 ± 1.32bB 4.66 ± 0.61bB 14.28 ± 1.06bA
Column corresponds to group comparisons at the specific time point (means with the same lowercase letter are not significantly different from each 
other). Row corresponds to time comparisons for each group (means with the same uppercase letter are not significantly different from each other).
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TABLE IV
MC3T3-E1 Cell Proliferation at Days 3, 5, and 7
Days
3 5 7
Group Mean (SD) Mean (SD) Mean (SD)
PLA 16.97 ± 3.59a,b 18.11 ± 4.42b,c 105.02 ± 13.05a,b
PCL 14.73 ± 1.82a,b 14.68 ± 3.28b,c 60.51 ± 14.94c
PLA:PCL 14.24 ± 1.04b 12.96 ± 1.83c 68.17 ± 20.87c
PLA:PCL + 5 wt % BBG 20.32 ± 2.66a 20.65 ± 5.17a,b 128.41 ± 19.23a
PLA:PCL + 10 wt % BBG 19.56 ± 5.14a,b 28.18 ± 10.18a 132.6 ± 10.04a
EpiGuide® 17.65 ± 3.93a,b 20.2 ± 2.8a,b 89.89 ± 9.85b,c
Different lowercase letters in the same column represent statistical differences between group and day.
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